MetaCap

Cencora (COR) vs EnerSyn Global (ESYN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cencora (COR) has outperformed EnerSyn Global (ESYN) over the past year, losing 7.3% versus a loss of 26.5%. Cencora is the larger company by market cap ($64.71 billion vs $37.4 million), about 1728.5 times the size. Cencora pays a dividend yielding 0.71%, while EnerSyn Global does not currently pay one.

Cencora converts more of its revenue into profit, with a net margin of 0.5% versus -303.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

COR-7.27%ESYN-26.49%
+83%+19%-45%
Nov 21, 20251 yearNov 20, 2026
COR+119.21%ESYN-97.73%
+152%+21%-110%
Mar 21, 20225 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

COR versus ESYN key metrics
MetricCORESYN
Share price$339.09$1.11
Market cap$64.71B$37.44M
1-day change-0.63%-0.89%
YTD return+0.40%-25.50%
1-year return-7.27%-26.49%
5-year return+182.03%—
P/E ratio (TTM)18.89—
Forward P/E15.60—
EPS (TTM)$17.95$-0.58
Dividend yield0.71%0.00%
Annual dividend$2.40$0.00
Revenue (latest FY)$321.33B$866.93K
Revenue growth (YoY)+9.31%-30.84%
Net income (latest FY)$1.55B$-2.63M
Gross margin3.57%53.03%
Operating margin0.82%—
Net margin0.48%-303.44%
52-week high$377.54$2.81
52-week low$244.82$0.88
Distance from 52-week high-10.18%-60.50%
Analyst consensusbuy—
Avg. price target upside+12.78%—
Average volume1.29M38.17K
Shares outstanding190.83M33.73M
Employees47,0004
SectorHealth CareHealth Care
IndustryOther PharmaceuticalsOther Pharmaceuticals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Cencora is about 1728.5 times larger than EnerSyn Global by market value ($64.71B vs $37.44M).
  • COR has outperformed ESYN by 19.2 percentage points over the past year.
  • Cencora is more profitable, keeping 0.5 cents of every revenue dollar as net income versus -303.4 cents for EnerSyn Global.
  • Cencora grew revenue faster in its latest fiscal year (+9.31% vs -30.84%).

About Cencora

COR stock →

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.

Health Care · Other Pharmaceuticals · 47,000 employees

About EnerSyn Global

ESYN stock →

EnerSyn Global Inc. engages in the food and beverage business in Singapore and South Korea.

Health Care · Other Pharmaceuticals · 4 employees

COR vs ESYN FAQ

Which is bigger, Cencora or EnerSyn Global?

Cencora (COR) is larger, with a market capitalization of $64.71B compared with $37.44M for EnerSyn Global (ESYN).

Which stock has performed better over the past year, COR or ESYN?

COR returned -7.27% over the past 12 months, compared with -26.49% for ESYN (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Cencora or EnerSyn Global?

Cencora pays a dividend yielding 0.71%, while EnerSyn Global does not currently pay a regular dividend.

Are Cencora and EnerSyn Global in the same industry?

Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.

More comparisons